TOT BIOPHARM International Yönetim
Yönetim kriter kontrolleri 3/4
We currently do not have sufficient information about the CEO.
Anahtar bilgiler
Jun Liu
İcra Kurulu Başkanı
CN¥7.5m
Toplam tazminat
| CEO maaş yüzdesi | 49.5% |
| CEO görev süresi | 5.7yrs |
| CEO sahipliği | n/a |
| Yönetim ortalama görev süresi | 4.2yrs |
| Yönetim Kurulu ortalama görev süresi | 5.7yrs |
Son yönetim güncellemeleri
Recent updates
We Think Some Shareholders May Hesitate To Increase TOT BIOPHARM International Company Limited's (HKG:1875) CEO Compensation
Jun 07
The Market Lifts TOT BIOPHARM International Company Limited (HKG:1875) Shares 29% But It Can Do More
May 21Is TOT BIOPHARM International (HKG:1875) Using Debt In A Risky Way?
Mar 18There's No Escaping TOT BIOPHARM International Company Limited's (HKG:1875) Muted Revenues
Dec 28Does TOT BIOPHARM International (HKG:1875) Have A Healthy Balance Sheet?
Nov 23We Think TOT BIOPHARM International (HKG:1875) Has A Fair Chunk Of Debt
May 18Here's Why We're Watching TOT BIOPHARM International's (HKG:1875) Cash Burn Situation
Jul 27An Intrinsic Calculation For TOT BIOPHARM International Company Limited (HKG:1875) Suggests It's 41% Undervalued
Mar 26Here's Why We're Watching TOT BIOPHARM International's (HKG:1875) Cash Burn Situation
Feb 03CEO Tazminat Analizi
| Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | CN¥9m |
| Mar 31 2024 | n/a | n/a | -CN¥14m |
| Dec 31 2023 | CN¥8m | CN¥4m | -CN¥38m |
| Sep 30 2023 | n/a | n/a | -CN¥44m |
| Jun 30 2023 | n/a | n/a | -CN¥49m |
| Mar 31 2023 | n/a | n/a | -CN¥50m |
| Dec 31 2022 | CN¥5m | CN¥3m | -CN¥50m |
| Sep 30 2022 | n/a | n/a | -CN¥106m |
| Jun 30 2022 | n/a | n/a | -CN¥162m |
| Mar 31 2022 | n/a | n/a | -CN¥212m |
| Dec 31 2021 | CN¥3m | CN¥2m | -CN¥261m |
Tazminat ve Piyasa: Jun's total compensation ($USD1.06M) is above average for companies of similar size in the Hong Kong market ($USD359.95K).
Tazminat ve Kazançlar: Jun's compensation has been consistent with company performance over the past year.
CEO
Jun Liu (56 yo)
5.7yrs
Görev süresi
CN¥7,528,000
Tazminat
Dr. Jun Liu serves as Chief Executive Officer at TOT BIOPHARM International Company Limited since October 15, 2020 and serves as its Executive Director since October 26, 2018. Dr. Liu serves as Chief Scien...
Liderlik Ekibi
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| CEO, Chief Scientific Officer & Executive Director | 5.7yrs | CN¥7.53m | Veri yok | |
| Executive Finance Director | 2.8yrs | Veri yok | Veri yok | |
| Joint Company Secretary | 5.6yrs | Veri yok | Veri yok | |
| Joint Company Secretary | 2.8yrs | Veri yok | Veri yok |
4.2yrs
Ortalama Görev Süresi
43yo
Ortalama Yaş
Deneyimli Yönetim: 1875's management team is considered experienced (4.2 years average tenure).
Yönetim Kurulu Üyeleri
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| CEO, Chief Scientific Officer & Executive Director | 6.1yrs | CN¥7.53m | Veri yok | |
| Chairman of the Board | 8.8yrs | Veri yok | Veri yok | |
| Independent Non-Executive Director | 5.7yrs | CN¥282.00k | Veri yok | |
| Non-Executive Vice Chairman of the Board | 8.8yrs | CN¥600.00k | 0.71% HK$ 10.2m | |
| Independent Non-Executive Director | 5.7yrs | CN¥282.00k | Veri yok | |
| Non-Executive Director | 1.3yrs | Veri yok | Veri yok | |
| Independent Non-Executive Director | 2.7yrs | CN¥282.00k | Veri yok |
5.7yrs
Ortalama Görev Süresi
56yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: 1875's board of directors are considered experienced (5.7 years average tenure).